Celiac Quick Test helps diagnose coeliac disease by detecting anti-tissue transglutaminase antibodies (tTG IgA/G/M) from finger prick blood samples (10min). Professional use only.
About
Coeliac disease is characterised by a permanent intolerance to gluten that affects 1% of the UKs population. It is an underdiagnosed and easily treatable condition that causes vague and common gastrointestinal symptoms. What's more, about 5% of first-degree relatives of coeliac sufferers, also have the condition. Testing for Coeliac disease is made simple with BIOHIT's Celiac Quick Test. In just 10 minutes this simple finger prick test gives a Positive or Negative result that can be relied upon, and actioned, from the convenience of a community setting. The BIOHIT Celiac Quick Test helps identify coeliac disease by measuring specific antibodies (anti-tissue Transglutaminase IgA/IgG/IgM) from a finger prick blood sample when it is applied to an immunochromatographic test cassette. Anti-tTG antibodies are measured routinely in medical laboraatories in the diagnosis of coeliac disease and have been shown to be highly specific for the condition. Each Celiac Quick Test kit contains 20 tests and all the equipment needed to perform the tests. Advantages: > Determination of tTG IgA/IgG/IgM antibodies (reduces risk of false negatives in IgA deficient individuals) > Can be used in doctors surgeries, outpatient clinics, pharmacies > Simple, safe and fast procedure > High accuracy > Results in 10 minutes > Suitable for adults and children
Key Benefits
Simple, safe and effective test that can be performed at the point of care Facilitates rapid diagnosis and treatment Avoids unnecessary healthcare investigations and consultations Applicable to adults and children and a large population Can be performed by healthcare professionals in any community setting
Applications
Pharmacy - perform the BIOHIT Celiac Quick Test in a consultation room as a first line test GP Practice - test and stratify patients according to clinical need Outpatient clinic - determine the need for further clinical tests and investigations